Page last updated: 2024-08-24

cidofovir anhydrous and Hematologic Neoplasms

cidofovir anhydrous has been researched along with Hematologic Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X1
Ader, F; Barraco, F; Ducastelle-Leprêtre, S; Gilis, L; Labussiere-Wallet, H; Lebras, L; Michallet, M; Nicolini, FE; Philippe, M; Ranchon, F; Rioufol, C; Salles, G; Schwiertz, V; Thomas, X; Vantard, N; Wattel, E1
Buxbaum-Conradi, H; Jäger, G; Kolb, HJ; Schleuning, M1
Basara, N; Kiehl, MG1
Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H1

Trials

1 trial(s) available for cidofovir anhydrous and Hematologic Neoplasms

ArticleYear
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation

2001

Other Studies

4 other study(ies) available for cidofovir anhydrous and Hematologic Neoplasms

ArticleYear
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2014, Volume: 49, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs Host Disease; Health Care Costs; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Incidence; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Risk Factors; Transplantation, Homologous; Tumor Virus Infections; Viremia; Young Adult

2014
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:4

    Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Middle Aged; Myeloablative Agonists; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Tumor Virus Infections; Viral Load

2016
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:2

    Topics: Adenoviridae; Adenovirus Infections, Human; Adolescent; Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Gastrointestinal Tract; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory System; Ribavirin; Treatment Outcome

2004
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting

2001